NCT07006207Not yet recruiting
Brain Olfactory Pathways in Prader-Willi Syndrome
Deciphering Brain Olfactory Pathways in Prader-Willi Syndrome
Source: ClinicalTrials.gov · Last updated 5 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Studying the cerebral activity of children with Prader-Willi Syndrom (PWS) when the study propose to them nasal activations.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 13 May 2025
- Start date
- 23 Jun 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- University Hospital, Toulouse
- NCT number
- NCT07006207
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 23 Jun 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergy to any of the fragrances used in the olfactory test
- Presence of an ENT infection such as rhinitis or sinusitis on the day of inclusion
Other
- Presence of a contraindication to MRI
- Reported anosmia
- Administrative problems.
Who the study is looking for
- child with a genetically confirmed diagnosis of PWS and for whom the genetic subtype (deletion or non deletion) has been identified
- Child aged between 5 and 7 years
- Child with a planned hospitalization at the Toulouse reference center for PWS
Age in the registry: 5 years to 7 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.